167 results on '"Verstappen, Suzanne M M"'
Search Results
2. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis
3. Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis
4. Predicting presenteeism using measures of health status
5. A general framework for selecting work participation outcomes in intervention studies among persons with health problems: a concept paper
6. Using qualitative methods for a conceptual analysis of measures of health status and presenteeism prior to a mapping study
7. Common Functional Ability Score for Young People With Juvenile Idiopathic Arthritis
8. Psychometric testing of the British‐English Perceived Workplace Support Scale, Work Accommodations, Benefits, Policies and Practices Scale, and Work Transitions Index in four rheumatic and musculoskeletal conditions.
9. Psychometric testing of the British‐English Long‐Term Conditions Job Strain Scale, Long‐Term Conditions Work Spillover Scale and Work‐Health‐Personal Life Perceptions Scale in four rheumatic and musculoskeletal conditions.
10. Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs.
11. Identification of Cell‐Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis.
12. Is the relationship between deprivation and outcomes in rheumatoid arthritis mediated by body mass index? A longitudinal cohort study.
13. Genome‐wide Association Study of Methotrexate‐Induced Liver Injury in Rheumatoid Arthritis Patients.
14. Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS)
15. Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study
16. Predictors of and outcomes following orthopaedic joint surgery in patients with early rheumatoid arthritis followed for 20 years
17. Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and Mendelian randomization.
18. Psychometric testing of the British English Workplace Activity Limitations Scale in four rheumatic and musculoskeletal conditions.
19. COVID-19-related anxiety trajectories in children, young people and adults with rheumatic diseases.
20. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases.
21. Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation.
22. Remotely collected patient-reported data characterises the impact of idiopathic inflammatory myopathy flares upon work productivity.
23. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
24. Increased Frailty in Individuals With Osteoarthritis and Rheumatoid Arthritis and the Influence of Comorbidity: An Analysis of the UK Biobank Cohort.
25. Pre-defined gene co-expression modules in rheumatoid arthritis transition towards molecular health following anti-TNF therapy.
26. Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis.
27. Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study.
28. Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach‡
29. Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register
30. Biologic therapies and pregnancy: the story so far
31. N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR)
32. Using lifestyle factors to identify individuals at higher risk of inflammatory polyarthritis (results from the European Prospective Investigation of Cancer-Norfolk and the Norfolk Arthritis Register—the EPIC-2-NOAR Study)
33. Demographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population
34. The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register
35. Learned helplessness predicts functional disability, pain and fatigue in patients with recent-onset inflammatory polyarthritis
36. 2010 ACR/EULAR classification criteria for rheumatoid arthritis predict increased mortality in patients with early arthritis: results from the Norfolk Arthritis Register
37. In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis
38. Methodological issues when measuring paid productivity loss in patients with arthritis using biologic therapies: an overview of the literature
39. In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: results from the Norfolk Arthritis Register
40. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
41. Why Do Patients with Inflammatory Arthritis Often Score States “Worse than Death” on the EQ-5D? An Investigation of the EQ-5D Classification System
42. Do people with rheumatoid arthritis maintain their physical activity level at treatment onset over the first year of methotrexate therapy?
43. Prevalence and predictors of adverse events with methotrexate mono- and combination-therapy for rheumatoid arthritis: a systematic review.
44. EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.
45. Changes in the illness perceptions of patients with rheumatoid arthritis over the first year of methotrexate therapy.
46. Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.
47. Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as 'satisfactory'.
48. Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis.
49. The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate.
50. Considerations for Evaluating and Recommending Worker Productivity Outcome Measures: An Update from the OMERACT Worker Productivity Group.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.